St. Luke’s Cancer Institute (SLCI) brings cutting-edge clinical trials to Idaho and the Northwest. A member of Children’s Oncology Group, SLCI provides access to experimental treatments usually only available at hospitals in larger metropolitan areas. Clinical trials often require participating hospitals to invest in specialized medical equipment and prescribe expensive, experimental therapies not covered by patients’ medical insurance. Funds contributed by KTM cover these research-related costs, enabling patients and St. Luke’s Cancer Institute itself to participate in studies they could not otherwise afford.
